Search Within

Genitourinary Oncology Service

Formats
  1. Journal Article (2795)
  2. Meeting Abstract (2526)
  3. Review (121)
  4. Book Section (83)
  5. Editorial (57)
  6. Correspondence (34)
  7. Conference Paper (29)
  8. Guidelines (25)
  9. Research Letter (18)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Solid Tumor Oncology Division (5696)
  2. Department of Medicine (5686)
  3. GSK Faculty (1659)
  4. Human Oncology and Pathogenesis Program (1158)
  5. Department of Pathology and Laboratory Medicine (1130)
  6. Surgery (1021)

More Groups

People
  1. Robert Motzer (1252)
  2. Howard Scher (1133)
  3. David Solit (786)
  4. Dean Bajorin (664)
  5. Michael Morris (588)
  6. Jonathan Rosenberg (525)

More People

Years
  1. 2025 (204)
  2. 2024 (294)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1713)
  2. Annals of Oncology (304)
  3. Clinical Cancer Research (283)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (123)

More Publications

Publishers
  1. American Society of Clinical Oncology (1780)
  2. American Association for Cancer Research (690)
  3. Oxford University Press (414)
  4. Elsevier Science, Inc. (396)
  5. Elsevier Inc. (380)
  6. Nature Publishing Group (304)

More Publishers

Results (5696)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • RECORD-4 multicenter phase 2 trial of second-line everolimus (EVE) in patients with metastatic renal cell carcinoma (mRCC): Anti-VEGF cohort subanalysis
    Meeting Abstract

    Cosgriff, T.; Yang, L.; Alyasova, A.; Ye, D.; Karpenko, A.; Alekseev, B.; Kowalyszyn, R.; Karyakin, O.; Neron, Y.; Collins, L. T.; more...
    BJU International (2016)

    Fulltext@MSK | Save
  • Anti-tumor activity of PEGylated human IL-10 (AM0010) in renal cancer alone and in combination with anti-PD1
    Meeting Abstract

    Naing, A.; Pant, S.; Infante, J.; Papadopoulos, K.; Autio, K.; Wong, D.; Ott, P.; Falchook, G.; Patel, M.; Whiteside, M.; more...
    BJU International (2016)

    Fulltext@MSK | Save
  • JAVELIN renal 101: A phase 3 study of avelumab in combination with axitinib vs sunitinib as first-line treatment for patients with advanced renal cell carcinoma (aRCC)
    Meeting Abstract

    Choueiri, T. K.; Rini, B. I.; Cosgriff, T.; Miyake, H.; Vogelzang, N. J.; Kannourakis, G.; Mariani, M.; Chiruzzi, C.; Albiges, L.; Haanen, J. B.; more...
    BJU International (2016)

    Fulltext@MSK | Save
  • A randomized phase 2 trial of CRLX101 in combination with bevacizumab in patients with metastatic renal cell carcinoma (mRCC) versus standard of care (SOC)
    Meeting Abstract

    Voss, M.; Hutson, T. E.; Hussain, A.; Vaishampayan, U.; Vogelzang, N. J.; Crowell, T.; Li, J.; Downing, W.; Senderowicz, A.; Stone, E.
    BJU International (2016)

    Fulltext@MSK | Save
  • Differential overall survival results in RECORD-3 study based on three distinct clear cell metastatic renal cell carcinoma molecular subgroups classified by BAP1 and/or PBRM1 mutations
    Meeting Abstract

    Hsieh, J.; Chen, D.; Wang, P.; Chen, Y. B.; Mahtab, M.; Pate, P.; Bhanot, U.; Berger, M.; Cheng, E.; Knox, J.; more...
    BJU International (2016)

    Fulltext@MSK | Save
  • Two-year efficacy and safety update from the phase III CheckMate 025 study of nivolumab versus everolimus in patients with advanced renal cell carcinoma (aRCC)
    Meeting Abstract

    Plimack, E. R.; Motzer, R. J.; Escudier, B.; Sharma, P.; McDermott, D. F.; George, S.; Hammers, H. J.; Carducci, M.; Tykodi, S. S.; Sosman, J. A.; more...
    BJU International (2016)

    Fulltext@MSK | Save
  • RECORD-4 multicenter phase 2 trial of second-line everolimus (EVE) in patients with metastatic renal cell carcinoma (mRCC): Anti-VEGF cohort subanalysis
    Meeting Abstract

    Cosgriff, T.; Yang, L.; Alyasova, A.; Ye, D.; Karpenko, A.; Alekseev, B.; Kowalyszyn, R.; Karyakin, O.; Neron, Y.; Collins, L. T.; more...
    BJU International (2016)

    Fulltext@MSK | Save
  • Treatment variance between experts and community clinicians: Analysis of an online decision tool for renal cell carcinoma (RCC)
    Meeting Abstract

    Rosenthal, K.; Choueiri, T.; Motzer, R.; Ryan, C.; Obholz, K.; Hutson, T.; Rini, B.
    BJU International (2016)

    Fulltext@MSK | Save
  • Medullary renal cell carcinoma (RCC): Genomics and treatment outcomes
    Meeting Abstract

    Lee, C. H.; Carlo, M.; Chen, Y.; Chaim, J.; Coskey, D.; Woo, K.; Voss, M.; Hsieh, J.; Feldman, D.; Motzer, R.
    BJU International (2016)

    Fulltext@MSK | Save
  • Genomic alterations and outcomes with targeted therapy in patients with clear cell renal cell carcinoma
    Meeting Abstract

    Carlo, M.
    BJU International (2016)

    Fulltext@MSK | Save